Akoya Biosciences Inc

NASDAQ AKYA

Data sourced from iex and EODHD
Download Data

Akoya Biosciences Inc Income Statement 2020 - 2024

This table shows the Income Statement for Akoya Biosciences Inc going from 2020 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenue
M 18 26 25 24 21 21 19 18 17 16 13 13 12 13 10 9 11
Cost of Revenue
M 10 12 10 11 9 9 8 8 7 6 5 5 5 5 4 3 4
Gross Profit
M 8 15 15 12 12 12 11 10 10 10 8 8 7 8 6 5 7
Operating Expenses
M 25 24 27 31 30 29 27 28 25 27 19 15 13 11 10 9 8
Selling, General, and Administrative Expenses (SG&A)
M 20 19 19 23 22 21 20 21 18 20 14 10 8 7 6 5 6
Research and Development (R&D) Expenses
M 6 5 5 6 6 6 5 6 6 6 4 3 3 3 2 2 2
Other Operating Expenses
M 0 0 3 2 2 1 1 2 1 1 1 1 1 2 2 2 -1
Costs and Expenses
M 15 12 14 19 20 20 19 20 19 20 14 9 8 5 5 5 5
Operating Income
M -17 -9 -12 -19 -17 -17 -16 -17 -15 -17 -11 -6 -5 -3 -4 -4 -1
Interest Expense
M 3 2 2 2 2 2 1 1 1 1 1 1 1 1 1 1 1
Non-operating Income/Expense
M -6 -2 -1 -1 -2 -2 -2 0 -1 -1 0 1 -2 -3 -1 -1 1
EBT
M -23 -11 -13 -21 -19 -19 -18 -17 -16 -18 -12 -6 -8 -6 -4 -5 -2
Income Tax Provision
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -23 -11 -13 -21 -19 -19 -18 -17 -16 -18 -12 -6 -8 -6 -4 -5 -2
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 1 1 - 1 1 1
Net Income
M - - - -21 -19 -19 -18 -17 -16 -18 -12 -6 -10 - -6 -6 -4
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 49,188,170.00 49,089,712.00 48,975,432.00 40,639,714.00 38,326,024.00 38,002,409.00 37,900,821.00 37,612,331.00 37,464,496.00 37,252,039.00 37,162,489.00 29,974,811.00 35,689,344.00 35,689,344.00 28,916,153.00 28,916,153.00 28,916,153.00
EBITDA
M -15 -7 -13 -16 -15 -15 -15 -16 -14 -15 -9 -5 -4 -1 -2 -2 -2
Depreciation and Amortization
M 2 2 2 2 3 2 2 1 2 1 1 1 1 1 1 1 1
EBIT
M -17 -9 -15 -18 -17 -17 -16 -17 -15 -16 -11 -6 -5 -2 -3 -3 -3
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -0.27 0.20 0.12 -0.09 -0.15 0.14 -0.12 -0.61 -0.13 0.66 0.09 0.11 0.07 0.45 0.21 -0.86 -1.81
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 0
Gross Profit Margin
% 45.66 55.67 60.58 51.51 57.42 56.77 57.86 57.79 59.76 63.29 62.73 62.23 60.64 61.26 60.62 61.57 60.76
Operating Income Margin
% -92.85 -33.31 -45.81 -81.81 -80.38 -80.56 -86.44 -97.60 -90.88 -103.85 -79.69 -48.80 -44.23 -24.40 -36.84 -44.77 -12.37
Net Income Margin
% - - - -88.44 -87.82 -88.95 -94.80 -97.77 -97.07 -109.38 -86.21 -46.70 -78.35 - -57.97 -70.92 -32.93
EBITDA Ratio
% -81.67 -25.36 -50.74 -69.01 -67.82 -69.74 -77.29 -89.86 -81.74 -90.04 -69.73 -37.46 -32.75 -10.05 -19.09 -27.00 -19.33
EBIT Ratio
% -92.85 -33.31 -60.16 -76.87 -80.38 -80.56 -86.44 -97.60 -90.88 -98.55 -78.96 -46.13 -41.28 -17.97 -28.84 -37.77 -27.48
EBT Ratio
% -127.63 -40.87 -51.16 -88.37 -87.68 -89.08 -94.69 -97.18 -96.94 -110.10 -86.29 -42.61 -66.23 -44.31 -43.13 -53.11 -19.10

StockViz Staff

September 16, 2024

Any question? Send us an email